Product Information

FUROSEMIDE 40 MG/4 ML VIAL is a generic product labeled by Avenacy Inc., priced at $0.2794 per ML under NDC 83634030204. Its NADAC has been published 106 times since Nov 13, 2024.

FDA first approved this application on Aug 26, 2014. Its Orange Book therapeutic-equivalence code is AP.

FUROSEMIDE 40 MG/4 ML VIAL

furosemide
$0.2794per ML

Strength

10 mg/mL

Manufacturer

Avenacy Inc.

NDC

83634030204

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAMUSCULAR; INTRAVENOUS

Effective Date

11/18/2026

Active Ingredients

FUROSEMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA203428

FDA Approved

8/26/2014

TE Code

AP

On Market Since

3/15/2024

Pharmacological Classes

Increased Diuresis at Loop of Henle
Loop Diuretic

Price Statistics

The NADAC for FUROSEMIDE 40 MG/4 ML VIAL has been published 106 times since Nov 13, 2024, and over the history we have for it it has declined 7.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2794 per ML
All-time high$0.3500 (May 13, 2026)
All-time low$0.2231 (Jun 18, 2025)
52-week high$0.3500
52-week low$0.2231
Median price$0.2334
Average price$0.2615
Largest weekly change+47.3% (Feb 18, 2026)
Weeks tracked106
Tracking sinceNov 13, 2024

Price History

1W

+5.6%

1M

+10.6%

3M

+5.1%

6M

-18.2%

1Y

+25.2%

3Y

N/A

5Y

N/A

All

-7.7%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FUROSEMIDE 40 MG/4 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for FUROSEMIDE 40 MG/4 ML VIAL, manufactured by Avenacy Inc., is $0.2794 per ML (NDC 83634030204), effective Nov 18, 2026.

How has the price of FUROSEMIDE 40 MG/4 ML VIAL changed over time?

Over the history we have for it, the NADAC for FUROSEMIDE 40 MG/4 ML VIAL has declined 7.7%. It has been tracked across 106 weekly CMS publications since Nov 13, 2024.

What are the highest and lowest recorded NADAC prices for FUROSEMIDE 40 MG/4 ML VIAL?

Since Nov 13, 2024, the NADAC for FUROSEMIDE 40 MG/4 ML VIAL has ranged from a low of $0.2231 (Jun 18, 2025) to a high of $0.3500 (May 13, 2026), with a median of $0.2334 per ML.

Are there cheaper alternatives to FUROSEMIDE 40 MG/4 ML VIAL?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FUROSEMIDE 40 MG/4 ML VIAL, is $0.2334 per ML — about 16% below FUROSEMIDE 40 MG/4 ML VIAL.

Who manufactures FUROSEMIDE 40 MG/4 ML VIAL?

FUROSEMIDE 40 MG/4 ML VIAL (NDC 83634030204) is labeled by Avenacy Inc., and CMS classifies it as a generic product.